nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—osteoporosis	0.597	1	CbGaD
Clenbuterol—CYP1A1—Cholecalciferol—osteoporosis	0.0702	0.29	CbGbCtD
Clenbuterol—CYP1A2—Estropipate—osteoporosis	0.0609	0.252	CbGbCtD
Clenbuterol—CYP1A1—Estradiol—osteoporosis	0.0566	0.234	CbGbCtD
Clenbuterol—NGF—sciatic nerve—osteoporosis	0.0478	0.984	CbGeAlD
Clenbuterol—CYP1A2—Conjugated Estrogens—osteoporosis	0.0288	0.119	CbGbCtD
Clenbuterol—CYP1A2—Estradiol—osteoporosis	0.0253	0.105	CbGbCtD
Clenbuterol—CYP1A1—uterus—osteoporosis	0.000759	0.0156	CbGeAlD
Clenbuterol—ADRB2—Signaling by GPCR—MGLL—osteoporosis	8.14e-05	0.000725	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LRP5—osteoporosis	8.09e-05	0.00072	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MYC—osteoporosis	8.04e-05	0.000716	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TGFB1—osteoporosis	8.02e-05	0.000715	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CALCA—osteoporosis	7.83e-05	0.000697	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—IL1B—osteoporosis	7.78e-05	0.000693	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LRP6—osteoporosis	7.74e-05	0.000689	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CALCA—osteoporosis	7.73e-05	0.000688	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PTHLH—osteoporosis	7.69e-05	0.000685	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	7.68e-05	0.000684	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CALCA—osteoporosis	7.65e-05	0.000682	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL6—osteoporosis	7.64e-05	0.000681	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.63e-05	0.00068	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CALCA—osteoporosis	7.45e-05	0.000664	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—TGFB1—osteoporosis	7.43e-05	0.000661	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—IL6—osteoporosis	7.38e-05	0.000657	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.23e-05	0.000644	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KL—osteoporosis	7.02e-05	0.000625	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—POMC—osteoporosis	6.9e-05	0.000614	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.87e-05	0.000612	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SOST—osteoporosis	6.85e-05	0.00061	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	6.79e-05	0.000605	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.78e-05	0.000604	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CALCA—osteoporosis	6.77e-05	0.000603	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SOST—osteoporosis	6.7e-05	0.000597	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TLN1—osteoporosis	6.53e-05	0.000582	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CALCR—osteoporosis	6.19e-05	0.000551	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTH1R—osteoporosis	6.19e-05	0.000551	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—MYC—osteoporosis	6.06e-05	0.00054	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PTH—osteoporosis	6.06e-05	0.00054	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTH1R—osteoporosis	6.06e-05	0.000539	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CALCR—osteoporosis	6.06e-05	0.000539	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—osteoporosis	6.05e-05	0.000539	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—osteoporosis	6.05e-05	0.000539	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	5.99e-05	0.000534	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	5.98e-05	0.000533	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	5.97e-05	0.000531	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PTH—osteoporosis	5.93e-05	0.000528	CbGpPWpGaD
Clenbuterol—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	5.91e-05	0.000527	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CNR2—osteoporosis	5.91e-05	0.000526	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.84e-05	0.00052	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CNR2—osteoporosis	5.78e-05	0.000515	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—POMC—osteoporosis	5.65e-05	0.000503	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—P4HB—osteoporosis	5.63e-05	0.000502	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.62e-05	0.000501	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—osteoporosis	5.6e-05	0.000498	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	5.57e-05	0.000496	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	5.57e-05	0.000496	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PTH—osteoporosis	5.5e-05	0.00049	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ADCY5—osteoporosis	5.5e-05	0.00049	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.48e-05	0.000488	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTH—osteoporosis	5.48e-05	0.000488	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.47e-05	0.000487	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.46e-05	0.000486	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PTH—osteoporosis	5.38e-05	0.00048	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RAP1A—osteoporosis	5.38e-05	0.00048	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.38e-05	0.000479	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CNR2—osteoporosis	5.36e-05	0.000478	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CNR2—osteoporosis	5.34e-05	0.000476	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—FDPS—osteoporosis	5.33e-05	0.000475	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PKM—osteoporosis	5.33e-05	0.000475	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SPP1—osteoporosis	5.32e-05	0.000474	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	5.3e-05	0.000472	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—ADCY5—osteoporosis	5.3e-05	0.000472	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.26e-05	0.000469	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NFATC1—osteoporosis	5.25e-05	0.000468	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CNR2—osteoporosis	5.25e-05	0.000467	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DKK1—osteoporosis	5.21e-05	0.000464	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—LEP—osteoporosis	5.15e-05	0.000459	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PGLS—osteoporosis	5.05e-05	0.00045	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPD2—osteoporosis	5.05e-05	0.00045	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—WNT1—osteoporosis	5.04e-05	0.000449	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PTHLH—osteoporosis	5.02e-05	0.000447	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—WNT1—osteoporosis	5.02e-05	0.000447	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—WNT1—osteoporosis	4.93e-05	0.00044	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MGLL—osteoporosis	4.92e-05	0.000438	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PTHLH—osteoporosis	4.91e-05	0.000438	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGA—osteoporosis	4.88e-05	0.000435	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—osteoporosis	4.84e-05	0.000431	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—ADCY5—osteoporosis	4.81e-05	0.000429	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MGLL—osteoporosis	4.81e-05	0.000429	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IRS2—osteoporosis	4.81e-05	0.000428	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LRP5—osteoporosis	4.8e-05	0.000428	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—LEP—osteoporosis	4.71e-05	0.000419	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LRP5—osteoporosis	4.7e-05	0.000418	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ATIC—osteoporosis	4.62e-05	0.000412	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PNP—osteoporosis	4.62e-05	0.000412	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LRP6—osteoporosis	4.59e-05	0.000409	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PTHLH—osteoporosis	4.56e-05	0.000406	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTHLH—osteoporosis	4.54e-05	0.000404	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—BMP2—osteoporosis	4.54e-05	0.000404	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ESR1—osteoporosis	4.49e-05	0.0004	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LRP6—osteoporosis	4.49e-05	0.0004	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PTHLH—osteoporosis	4.46e-05	0.000397	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGB—osteoporosis	4.44e-05	0.000396	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CALCA—osteoporosis	4.42e-05	0.000394	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.38e-05	0.00039	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CALCA—osteoporosis	4.33e-05	0.000385	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6R—osteoporosis	4.32e-05	0.000385	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PSMA5—osteoporosis	4.29e-05	0.000382	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PSMA2—osteoporosis	4.29e-05	0.000382	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IRS1—osteoporosis	4.2e-05	0.000374	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—POMC—osteoporosis	4.09e-05	0.000365	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—POMC—osteoporosis	4.04e-05	0.00036	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CALCA—osteoporosis	4.02e-05	0.000358	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—POMC—osteoporosis	4e-05	0.000357	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CALCA—osteoporosis	4e-05	0.000356	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6R—osteoporosis	3.94e-05	0.000351	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CALCA—osteoporosis	3.93e-05	0.00035	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—OXCT1—osteoporosis	3.93e-05	0.00035	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CA2—osteoporosis	3.93e-05	0.00035	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—POMC—osteoporosis	3.9e-05	0.000347	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IGF1—osteoporosis	3.89e-05	0.000346	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TLN1—osteoporosis	3.88e-05	0.000345	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MGLL—osteoporosis	3.83e-05	0.000341	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TLN1—osteoporosis	3.79e-05	0.000338	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.73e-05	0.000332	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KL—osteoporosis	3.63e-05	0.000323	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.61e-05	0.000322	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—POMC—osteoporosis	3.6e-05	0.000321	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—POMC—osteoporosis	3.54e-05	0.000315	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6R—osteoporosis	3.45e-05	0.000308	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—FDPS—osteoporosis	3.4e-05	0.000303	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PKM—osteoporosis	3.4e-05	0.000303	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—P4HB—osteoporosis	3.34e-05	0.000298	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—P4HB—osteoporosis	3.27e-05	0.000291	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—IDH2—osteoporosis	3.25e-05	0.00029	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTH—osteoporosis	3.25e-05	0.00029	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PGLS—osteoporosis	3.22e-05	0.000287	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPD2—osteoporosis	3.22e-05	0.000287	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RAP1A—osteoporosis	3.2e-05	0.000285	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTH—osteoporosis	3.18e-05	0.000283	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CNR2—osteoporosis	3.17e-05	0.000282	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—ADCY5—osteoporosis	3.15e-05	0.00028	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RAP1A—osteoporosis	3.13e-05	0.000278	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NFATC1—osteoporosis	3.12e-05	0.000278	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CNR2—osteoporosis	3.1e-05	0.000276	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DKK1—osteoporosis	3.09e-05	0.000276	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—ADCY5—osteoporosis	3.08e-05	0.000274	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP27A1—osteoporosis	3.06e-05	0.000273	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NFATC1—osteoporosis	3.05e-05	0.000272	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DKK1—osteoporosis	3.03e-05	0.00027	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—WNT1—osteoporosis	2.98e-05	0.000265	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ACP5—osteoporosis	2.98e-05	0.000265	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PNP—osteoporosis	2.95e-05	0.000262	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ATIC—osteoporosis	2.95e-05	0.000262	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.94e-05	0.000262	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—WNT1—osteoporosis	2.91e-05	0.00026	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGA—osteoporosis	2.9e-05	0.000258	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	2.86e-05	0.000254	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADCY5—osteoporosis	2.84e-05	0.000253	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGA—osteoporosis	2.84e-05	0.000253	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	2.79e-05	0.000249	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TPI1—osteoporosis	2.77e-05	0.000247	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SPP1—osteoporosis	2.75e-05	0.000245	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTHLH—osteoporosis	2.69e-05	0.00024	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BMP2—osteoporosis	2.69e-05	0.00024	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGB—osteoporosis	2.64e-05	0.000235	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTHLH—osteoporosis	2.64e-05	0.000235	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BMP2—osteoporosis	2.64e-05	0.000235	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—P4HB—osteoporosis	2.6e-05	0.000232	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGB—osteoporosis	2.58e-05	0.00023	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GAPDH—osteoporosis	2.55e-05	0.000228	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—osteoporosis	2.55e-05	0.000227	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PSMA5—osteoporosis	2.55e-05	0.000227	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PSMA2—osteoporosis	2.55e-05	0.000227	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CA2—osteoporosis	2.5e-05	0.000223	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—OXCT1—osteoporosis	2.5e-05	0.000223	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PSMA2—osteoporosis	2.49e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PSMA5—osteoporosis	2.49e-05	0.000222	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—RAP1A—osteoporosis	2.49e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IRS2—osteoporosis	2.49e-05	0.000222	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MGLL—osteoporosis	2.44e-05	0.000217	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LEP—osteoporosis	2.43e-05	0.000217	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CALCA—osteoporosis	2.37e-05	0.000211	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYC—osteoporosis	2.34e-05	0.000208	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—osteoporosis	2.33e-05	0.000208	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ESR1—osteoporosis	2.32e-05	0.000207	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CALCA—osteoporosis	2.32e-05	0.000207	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—POMC—osteoporosis	2.31e-05	0.000206	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.3e-05	0.000205	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—POMC—osteoporosis	2.26e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IRS1—osteoporosis	2.17e-05	0.000193	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.17e-05	0.000193	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KL—osteoporosis	2.15e-05	0.000192	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KL—osteoporosis	2.11e-05	0.000188	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—POMC—osteoporosis	2.1e-05	0.000187	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—POMC—osteoporosis	2.09e-05	0.000186	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—IDH2—osteoporosis	2.08e-05	0.000185	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—POMC—osteoporosis	2.06e-05	0.000183	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6R—osteoporosis	2.05e-05	0.000183	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6R—osteoporosis	2.04e-05	0.000182	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF1—osteoporosis	2.01e-05	0.000179	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ENO1—osteoporosis	2.01e-05	0.000179	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6R—osteoporosis	2e-05	0.000179	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PSMA5—osteoporosis	1.98e-05	0.000177	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PSMA2—osteoporosis	1.98e-05	0.000177	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.95e-05	0.000174	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—osteoporosis	1.92e-05	0.000171	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ACP5—osteoporosis	1.9e-05	0.000169	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.87e-05	0.000167	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TPI1—osteoporosis	1.76e-05	0.000157	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—osteoporosis	1.76e-05	0.000156	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADCY5—osteoporosis	1.69e-05	0.00015	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—P4HB—osteoporosis	1.66e-05	0.000148	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADCY5—osteoporosis	1.65e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SPP1—osteoporosis	1.63e-05	0.000145	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GAPDH—osteoporosis	1.63e-05	0.000145	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP19A1—osteoporosis	1.61e-05	0.000143	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SPP1—osteoporosis	1.6e-05	0.000142	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—RAP1A—osteoporosis	1.59e-05	0.000141	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—osteoporosis	1.54e-05	0.000137	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.48e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LEP—osteoporosis	1.44e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IRS2—osteoporosis	1.44e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LEP—osteoporosis	1.41e-05	0.000126	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.38e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.38e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ESR1—osteoporosis	1.35e-05	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ADCY5—osteoporosis	1.31e-05	0.000117	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPX1—osteoporosis	1.31e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IRS1—osteoporosis	1.29e-05	0.000115	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ENO1—osteoporosis	1.28e-05	0.000114	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PSMA5—osteoporosis	1.26e-05	0.000113	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PSMA2—osteoporosis	1.26e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IRS1—osteoporosis	1.26e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—POMC—osteoporosis	1.24e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—POMC—osteoporosis	1.21e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6R—osteoporosis	1.21e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—osteoporosis	1.21e-05	0.000108	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—osteoporosis	1.21e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—osteoporosis	1.21e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1—osteoporosis	1.19e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6R—osteoporosis	1.18e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1—osteoporosis	1.17e-05	0.000104	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.03e-05	9.13e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—POMC—osteoporosis	9.66e-06	8.61e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—osteoporosis	9.13e-06	8.13e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—osteoporosis	9.09e-06	8.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—osteoporosis	8.93e-06	7.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ADCY5—osteoporosis	8.37e-06	7.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPX1—osteoporosis	8.35e-06	7.44e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—osteoporosis	7.7e-06	6.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—osteoporosis	7.17e-06	6.39e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—osteoporosis	7.16e-06	6.38e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—osteoporosis	7.02e-06	6.25e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—osteoporosis	7e-06	6.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—POMC—osteoporosis	6.16e-06	5.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—osteoporosis	5.39e-06	4.8e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—osteoporosis	5.28e-06	4.7e-05	CbGpPWpGaD
